Travere Therapeutics, Inc. (TVTX)
51.80
-0.22
(-0.42%)
USD |
NASDAQ |
Oct 13, 16:00
51.76
-0.04
(-0.08%)
After-Hours: 20:00
Travere Therapeutics Total Return Price : 51.80 for Oct. 13, 2026
Total Return Price Chart
Historical Total Return Price Data
| Date | Value |
|---|---|
| October 13, 2026 | 51.80 |
| October 12, 2026 | 52.02 |
| October 09, 2026 | 52.12 |
| October 08, 2026 | 52.04 |
| October 07, 2026 | 53.44 |
| October 06, 2026 | 55.98 |
| October 05, 2026 | 57.67 |
| October 02, 2026 | 56.93 |
| October 01, 2026 | 56.85 |
| September 30, 2026 | 58.88 |
| September 29, 2026 | 59.99 |
| September 28, 2026 | 61.57 |
| September 25, 2026 | 59.44 |
| September 24, 2026 | 60.62 |
| September 23, 2026 | 59.83 |
| September 22, 2026 | 60.28 |
| September 21, 2026 | 62.86 |
| September 18, 2026 | 62.76 |
| September 17, 2026 | 64.74 |
| September 16, 2026 | 63.48 |
| September 15, 2026 | 62.51 |
| September 14, 2026 | 65.79 |
| September 11, 2026 | 66.17 |
| September 10, 2026 | 67.51 |
| September 09, 2026 | 66.22 |
| Date | Value |
|---|---|
| September 08, 2026 | 66.07 |
| September 04, 2026 | 65.28 |
| September 03, 2026 | 66.54 |
| September 02, 2026 | 67.23 |
| September 01, 2026 | 65.71 |
| August 31, 2026 | 66.28 |
| August 28, 2026 | 65.67 |
| August 27, 2026 | 67.52 |
| August 26, 2026 | 67.12 |
| August 25, 2026 | 67.01 |
| August 24, 2026 | 65.22 |
| August 21, 2026 | 65.71 |
| August 20, 2026 | 64.46 |
| August 19, 2026 | 65.96 |
| August 18, 2026 | 63.90 |
| August 17, 2026 | 63.53 |
| August 14, 2026 | 62.14 |
| August 13, 2026 | 61.43 |
| August 12, 2026 | 62.16 |
| August 11, 2026 | 60.21 |
| August 10, 2026 | 60.89 |
| August 07, 2026 | 61.32 |
| August 06, 2026 | 62.45 |
| August 05, 2026 | 62.76 |
| August 04, 2026 | 56.02 |
Total Return Price Definition
The total return price allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions.
Total Return Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Price Benchmarks
| TG Therapeutics, Inc. | 54.34 |
| BioMarin Pharmaceutical, Inc. | 54.38 |
| Vertex Pharmaceuticals, Inc. | 485.22 |
| Viridian Therapeutics, Inc. | 18.22 |
| Krystal Biotech, Inc. | 321.16 |